Thursday, November 11, 2021 12:07:14 AM
HGEN has no production. None. Zippo. Zero. Nothing. Yet, because others are getting multi-billion dollar contracts you think the UK, Europe or the U.S. is going to approve Lenz that has no production and at best can produce 100k treatments in the next 12 months, which costs a ridiculous amount to produce per treatment and shows marginable benefits at best?
Let's get back in reality boys and girls...
Vaccine rates have moved up significantly and continue to move substantially higher as children become vaccinated, booster shots for adults are and continue to become more readily available (and are dirty cheap) and thus, herd immunity will be here in no time. Throw in PFE's Paxlovid Antiviral drug and the need for Lenz falls by the second.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM